Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive disease.
Wiesli
Peter
P
Schulthess
Georg
G
D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000150:complications*; D023521:Chlamydophila Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016993:Chlamydophila pneumoniae / Q000276:immunology; D004351:Drug Resistance; D004730:Endothelium, Vascular / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000150:complications*; D017534:Radial Artery / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D015575:Roxithromycin / Q000494:pharmacology* / Q000627:therapeutic use; D012907:Smoking; D014463:Ultrasonography; D014664:Vasodilation / Q000187:drug effects
D000900:Anti-Bacterial Agents; D015575:Roxithromycin